Health Condition 1: J06- Acute upper respiratory infectionsof multiple and unspecified sites
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Adolescent age group (10 to 19 years) and Adult (19 to 60) age group 2) Either sex group or transgender 3) Clinical signs and symptoms of an URTI with a duration of greater than 24 hours with or without a fever greater than 37.5 degrees Celsius (axillary body temperature). 4) At least 1 of 3 types of URTI symptoms?nasal (plugged nose, runny nose, sneezing), pharyngeal (scratchy throat, sore throat, pharyngeal hyperaemia), and cough (ordinary cough without suspicion of acute lower respiratory tract disease) 5) At least 1 of 5 general symptoms?feeling tired, weakness, body ache, irritable or whining, or less active
Exclusion criteria
Exclusion criteria: 1) Not providing written assent or consent of participation. 2) Progress to lower respiratory tract infection and Severe or complicated course of URTI?e.g., bronchitis, pneumonia etc. 3) Severe concomitant diseases (renal failure, heart anomalies, circulatory failure, cardiomyopathy, decompensated kidney and liver, immunosuppressive conditions, and oncological diseases). 4) Known or suspected hypersensitivity to any component of the study medication 5) Use of immunomodulatory medications. 6) Being vaccinated against influenza within the last 6 months before the start of the study. 7) Vulnerable population?unconscious, non-ambulatory, too sick for consultation, differently abled, or terminally or critically ill. 8) Subjects undergoing homeopathic treatment for any chronic disease(s) within last 15 days 9) Simultaneous participation in any other clinical trial. 10) History of atopy & allergy 11) Fever more than 105 degree F 12) Oxygen saturation level below 90 percent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Time (Day) to complete resolution of symptoms of URTI.Timepoint: 15 days of intervention | — |
Secondary
| Measure | Time frame |
|---|---|
| Canadian Acute Respiratory Illness and Flu Scale (CARIFS)Timepoint: Baseline and at days 1, 2, 3, 5, 7, 10, and 15 of intervention.;Wisconsin Upper Respiratory Symptom Survey (WURSS-21)Timepoint: Baseline and at days 1, 2, 3, 5, 7, 10, and 15 of intervention.;Complete blood count (CBC)Timepoint: At baseline and after 15 days of intervention. | — |
Countries
India
Contacts
D N De Homoeopathic Medical College and Hospital